Baird Financial Group’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322K Buy
+3,278
New +$308K ﹤0.01% 1702
2023
Q2
Sell
-3,795
Closed -$316K 1724
2023
Q1
$316K Hold
3,795
﹤0.01% 1479
2022
Q4
$322K Hold
3,795
﹤0.01% 1430
2022
Q3
$286K Hold
3,795
﹤0.01% 1483
2022
Q2
$308K Sell
3,795
-240
-6% -$20.1K ﹤0.01% 1546
2022
Q1
$354K Sell
4,035
-55
-1% -$4.65K ﹤0.01% 1562
2021
Q4
$369K Sell
4,090
-1
-0% -$86 ﹤0.01% 1592
2021
Q3
$343K Hold
4,091
﹤0.01% 1616
2021
Q2
$340K Buy
4,091
+862
+27% +$69.7K ﹤0.01% 1542
2021
Q1
$249K Buy
+3,229
New +$249K ﹤0.01% 1575
2016
Q3
Sell
-9,500
Closed -$480K 1209
2016
Q2
$480K Buy
+9,500
New +$474K ﹤0.01% 926

Other funds holding IXJ

Baird Financial Group's IXJ Position: Q2 2026 in Review

Baird Financial Group opened a new position in iShares Global Healthcare ETF (IXJ) in Q2 2026: 3,278 shares worth $322K. The stake represents ﹤0.01% of the portfolio and ranks #1702 among its holdings. This is a return to the name: Baird Financial Group previously reported a position in IXJ as recently as Q1 2023.

Baird Financial Group first reported a position in IXJ in Q2 2016 and has held it in 11 quarters since. The position peaked at $480K in Q2 2016. 302 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Baird Financial Group held 3,278 shares of iShares Global Healthcare ETF worth $322K as of Q2 2026.
  • iShares Global Healthcare ETF was a new Baird Financial Group position in Q2 2026.
  • iShares Global Healthcare ETF made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #1702 holding.
  • Baird Financial Group first reported a position in iShares Global Healthcare ETF in Q2 2016 and has held it in 11 quarters since.
  • Baird Financial Group's iShares Global Healthcare ETF position peaked at $480K in Q2 2016.
  • 302 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.